Sizmek Inc.

(SZMK) Trade

By |

Profile

Bioasis Technologies Inc is a development stage biopharmaceutical company. It is engaged in the research and development of products for the diagnosis and treatment of neurological disease and disorders. The company has worked on blood-brain barrier program and studies disorders in the brain. The company's xB3 program describes its proprietary carrier, p97, and components thereof, to deliver therapeutics across the blood-brain barrier (BBB). Its source of revenue is research revenue and license revenue.

Contact Information

Website: www.bioasis.us
Email: info@bioasis.us
Main Phone: +1 917 763-2709
Address: 14 Water Street
Address 2: Suite 130
State: CT
City / Town: Guilford
Country: USA
Postal Code: 06437

Issuer Information

Exchange: NGS
CEO: Deborah Ann Rathjen
Employees: 1204
NAICS: Pharmaceutical Preparation Manufacturing(325412)

Equities News

Profile

Bioasis Technologies Inc is a development stage biopharmaceutical company. It is engaged in the research and development of products for the diagnosis and treatment of neurological disease and disorders. The company has worked on blood-brain barrier program and studies disorders in the brain. The company's xB3 program describes its proprietary carrier, p97, and components thereof, to deliver therapeutics across the blood-brain barrier (BBB). Its source of revenue is research revenue and license revenue.

Contact Information

Website: www.bioasis.us
Email: info@bioasis.us
Main Phone: +1 917 763-2709
Address: 14 Water Street
Address 2: Suite 130
State: CT
City / Town: Guilford
Country: USA
Postal Code: 06437

Issuer Information

Exchange: NGS
CEO: Deborah Ann Rathjen
Employees: 1204
NAICS: Pharmaceutical Preparation Manufacturing(325412)

Equities News

(%)
Company data no longer available
Last Price N/A Change $ N/A Change % N/A Tick N/A
Bid N/A Bid Size 0.00 Ask N/A Ask Size 0.00
Open N/A High N/A Low N/A Prev Close N/A
Last Trade Volume 0 52 Wk Hi 6.77 52 Wk Low 2.09
Market Cap N/A Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 63,209,740.00 EPS (TTM) N/A PE Ratio N/A Exchange NGS
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 3.9 3.9 3.9 3.9
Low Target Price Estimate 3.9 3.9 3.9 3.9
Mean Target Price Estimate 3.9 3.9 3.9 3.9
Standard Deviation 0 0 0 0
Date of Most Recent Estimate 08/03/16 08/03/16 08/03/16 08/03/16
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 0 0 0 0
Moderate Buy 0 0 0 0
Hold 0 1 1 1
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 0 3 3 3